IDEAYA Biosciences (IDYA) Short-term Investments (2018 - 2026)

IDEAYA Biosciences has reported Short-term Investments for 9 years, with the latest figure at $513.7 million in Q1 2026.

• Quarterly Short-term Investments fell 45.55% year-over-year to $513.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $513.7 million (down 45.55% YoY) and the FY2025 annual result came in at $526.6 million, down 11.04% from the prior year.
• Short-term Investments fell to $513.7 million in Q1 2026 per IDYA's latest filing, from $526.6 million in the prior quarter.
• Over five years, Short-term Investments peaked at $943.4 million in Q1 2025 and troughed at $197.3 million in Q1 2022.
• A 5-year average of $446.6 million and a median of $488.0 million in 2025 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2024 and 2026: Short-term Investments jumped 116.88% in 2024, then sank 45.55% in 2026.
• Over 5 years, Short-term Investments stood at $296.2 million in 2022, then climbed by 24.27% to $368.1 million in 2023, then surged by 60.81% to $591.9 million in 2024, then decreased by 11.04% to $526.6 million in 2025, then declined by 2.45% to $513.7 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $513.7 million, $526.6 million, and $488.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.